In today’s fast-paced scientific and regulatory ecosystem, biomedical research is expanding at an unprecedented pace. Thousands of new studies, publications, and safety updates are released daily across global journals, regulatory databases, and scientific platforms. For organizations in the pharmaceutical, biotechnology, CRO, and medical device sectors, staying on top of this constant flow of information is not just about knowledge — it is a compliance requirement enforced by international authorities.
Yet, the reality is daunting: manual literature searches are resource-heavy, error-prone, and time-consuming. Teams spend countless hours screening through data, while still facing the risk of missed safety signals, overlooked evidence, or delays in reporting — all of which can compromise patient safety and regulatory trust.
This challenge is exactly where AutoLit makes a difference. Designed as a
next-generation,
AI-powered literature intelligence tool, AutoLit redefines how organizations approach
literature monitoring, evidence extraction, and compliance reporting. By automating
repetitive
tasks, intelligently filtering results, and generating audit-ready documentation, AutoLit
empowers companies to achieve unmatched efficiency, accuracy, and compliance confidence.
More than just a tool, AutoLit is a strategic enabler — helping your teams focus on
decisionmaking and patient safety, while we take care of the constant, complex, and evolving
task of
literature surveillance. With seamless integration and global scalability, AutoLit
transforms a
regulatory burden into an opportunity for smarter insights, faster responses, and long-term
compliance excellence.
Over 80% of pharmacovigilance activities rely on continuous literature monitoring to detect emerging safety signals.
Why Choose AutoLit?
✔ Save Time & Resources – Reduce manual hours spent on literature monitoring by up to 70%
✔ Accuracy at Scale – AI-enabled screening minimizes the risk of oversight
✔ Global Compliance – Aligned with Good Pharmacovigilance Practices (GVP) and global standards.
✔ End-to-End Solution – From search to reporting, all in one streamlined tool.
✔ Future-Ready – Continuous learning keeps AutoLit adaptive to evolving data and regulations
Industries That Benefit
❄︎ CROs managing literature monitoring for multiple sponsors.
❄︎ Regulatory & Research institutions requiring structured evidence monitoring
AutoLit at a Glance
“One platform. Complete visibility. Total compliance.”
With AutoLit, you gain control, clarity, and confidence in every literature search — freeing your teams to focus on strategy, insights, and safer outcomes for patients.
Get in touch with our Medical Device Experts today